Literature DB >> 23275112

Biocompatibility and levofloxacin delivery of mesoporous materials.

Mónica Cicuéndez1, Isabel Izquierdo-Barba, María Teresa Portolés, María Vallet-Regí.   

Abstract

A comparative study of mesoporous matrices designed for both drug-loading methods, impregnation (IP) and surfactant-assisted drug loading (also denoted as one-pot, OP), has been carried out evaluating their physicochemical characteristics, cell response, drug delivery profiles, and antibacterial activity. Surfactant-free (calcined) and surfactant-templated (non-calcined) mesoporous silica have been used as IP and OP starting matrices, respectively. Both non-calcined and calcined matrices do not exert any cytotoxic effect on osteoblasts. However, non-calcined matrices induce on fibroblasts a significant proliferation delay with morphological alterations and dose-dependent increases in fibroblast size, internal complexity, and intracellular calcium content but without cell lysis and apoptosis. Residual ethanol and the surface silanol groups in these non-calcined matrices are involved in the observed fibroblast changes. Finally, both IP and OP matrices have been loaded with levofloxacin to compare them as drug delivery systems. Both IP and OP matrices exhibit similar in vitro levofloxacin release profiles, showing an initial fast delivery followed by a sustained release during long time periods. These profiles and the antimicrobial activity results suggest the use of these IP and OP matrices as local drug delivery systems in the osteomyelitis and other bone infection treatments.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275112     DOI: 10.1016/j.ejpb.2012.11.029

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

1.  Impact of the antibiotic-cargo from MSNs on Gram-positive and Gram-negative bacterial biofilms.

Authors:  Anna Aguilar-Colomer; Montserrat Colilla; Isabel Izquierdo-Barba; Carla Jiménez-Jiménez; Ignacio Mahillo; Jaime Esteband; María Vallet-Regí
Journal:  Microporous Mesoporous Mater       Date:  2020-10-07       Impact factor: 5.876

2.  Evaluation of the in vitro biocompatibility of PMMA/high-load HA/carbon nanostructures bone cement formulations.

Authors:  Gil Gonçalves; María-Teresa Portolés; Cecilia Ramírez-Santillán; María Vallet-Regí; Ana Paula Serro; José Grácio; Paula A A P Marques
Journal:  J Mater Sci Mater Med       Date:  2013-08-21       Impact factor: 3.896

3.  Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties.

Authors:  Noemí Encinas; Mercedes Angulo; Carlos Astorga; Montserrat Colilla; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Acta Biomater       Date:  2018-12-06       Impact factor: 8.947

4.  Multifunctional antibiotic- and zinc-containing mesoporous bioactive glass scaffolds to fight bone infection.

Authors:  C Heras; J Jiménez-Holguín; A L Doadrio; M Vallet-Regí; S Sánchez-Salcedo; A J Salinas
Journal:  Acta Biomater       Date:  2020-07-24       Impact factor: 10.633

5.  Boosting Antimicrobial Activity of Ciprofloxacin by Functionalization of Mesoporous Silica Nanoparticles.

Authors:  Blanca de Juan Mora; Luís Filipe; Andreia Forte; Miguel M Santos; Celso Alves; Fernando Teodoro; Rui Pedrosa; Manuela Ribeiro Carrott; Luís C Branco; Sandra Gago
Journal:  Pharmaceutics       Date:  2021-02-05       Impact factor: 6.321

Review 6.  Mesoporous Bioglasses Enriched with Bioactive Agents for Bone Repair, with a Special Highlight of María Vallet-Regí's Contribution.

Authors:  Antonio J Salinas; Pedro Esbrit
Journal:  Pharmaceutics       Date:  2022-01-15       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.